Tag
APL Healthcare Limited
2 articles
Aurobindo Pharma USFDA Dapagliflozin Approval
Aurobindo Pharma received USFDA final approval for Dapagliflozin Tablets, 5 mg and 10 mg, a generic equivalent to AstraZeneca's Farxiga.
The product has an estimated market size of US$10.2 billion for
Aurobindo Pharma USFDA Approval Dapagliflozin Metformin
Aurobindo Pharma received final USFDA approval to manufacture and market Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets.
The approved product has an estimated market size of US$514